MediFind
Condition

Fragile XE Syndrome

Latest Research

Latest Advance
Study
  • Condition: Children with Fragile X Syndrome (FXS)
  • Journal: Molecular genetics & genomic medicine
  • Treatment Used: Metformin
  • Number of Patients: 9
  • Published —
This study presented children with fragile X syndrome (FXS) between 2 and 7 years of age who were treated clinically with metformin and monitored for behavioral and metabolic changes.
Latest Advance
Study
  • Condition: Fragile X Syndrome
  • Journal: Journal of autism and developmental disorders
  • Treatment Used: Social avoidance
  • Number of Patients: 191
  • Published —
This article discusses the prevalence of social avoidance in fragile X syndrome.
Latest Advance
Study
  • Condition: Fragile X Syndrome
  • Journal: Molecular genetics & genomic medicine
  • Treatment Used: Metformin
  • Number of Patients: 2
  • Published —
This case report describes two patients with fragile X syndrome that were treated using metformin.
Latest Advance
Study
  • Condition: Fragile X Syndrome (FXS)
  • Journal: Journal of autism and developmental disorders
  • Treatment Used: Telehealth
  • Number of Patients: 10
  • Published —
This study evaluated the effectiveness of telehealth behavioral treatment for reducing problem behavior in patients with fragile X syndrome (an inherited condition characterized by an X chromosome that is abnormally susceptible to damage).
Latest Advance
Study
  • Condition: Fragile X Syndrome
  • Journal: Scientific reports
  • Treatment Used: Mavoglurant
  • Number of Patients: 267
  • Published —
In this study, researchers evaluated the safety and effectiveness of mavoglurant for the treatment of fragile X syndrome.
Latest Advance
Study
  • Condition: Males with Fragile X-Associated Tremor/Ataxia Syndrome (TXTAS)
  • Journal: Molecular neurobiology
  • Treatment Used: Allopregnanolone Treatment
  • Number of Patients: 6
  • Published —
This study evaluated the effectiveness of allopregnanolone (a medication and a naturally produced steroid that acts on the brain) treatment in males with fragile X-associated tremor/ataxia syndrome (disorder characterized by problems with movement and thinking ability; FXTAS).